A Study to Test the Effects of BMS-986036 on the Body in Healthy Japanese and Non-Japanese Subjects

Completed · Phase 1 · Has a placebo group

Conditions studied: Metabolics

In brief

The purpose of this study is to evaluate safety, and tolerability of BMS-986036 and the effects the drug has on the body

Key facts

Study ID

NCT03198182

Run by

Bristol-Myers Squibb

People needed

63

Starts

2017-06-28

Expected to finish

2017-09-22

Last updated by the study team

2019-05-01

Who can join

Age: 21 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy subjects, as determined by no clinically significant deviations from normal in medical history, physical examination, electrocardiograms (ECGs), and clinical laboratory determinations
• Body mass index (BMI) of 25 to 40 kilogram / square meter (kg/m2), inclusive
• Additional criterion for Japanese subjects: Subjects must be first generation Japanese (born in Japan and not living outside of Japan for > 10 years, and both parents are ethnically Japanese)

You may not qualify if…

• Presence of any factors that would predispose the subject to infection (extensive periodontal disease that warrants surgical or medical treatment, unhealed open wounds)
• Any bone trauma (fracture) or bone surgery (hardware placement, joint replacement, bone grafting, or amputation) within 3 months of study drug administration
• Known or suspected autoimmune disorder, excluding vitiligo
• Other protocol defined inclusion/exclusion criteria could apply

Where it is running

• WCCT Global — Cypress, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.